2022
DOI: 10.1016/j.jconrel.2022.01.014
|View full text |Cite
|
Sign up to set email alerts
|

A smart cauliflower-like carrier for astaxanthin delivery to relieve colon inflammation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
33
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2
1

Relationship

2
6

Authors

Journals

citations
Cited by 55 publications
(37 citation statements)
references
References 43 publications
1
33
0
Order By: Relevance
“…The treatment of human macrophages with krill oil-rich in PUFAs and astaxanthin-resulted in a reduction in LPS-induced IL-1β and TNF-α expression in vitro in a concentration-dependent manner. Astaxanthin also decreased the amount of Rickettsiales and several Lactobacillus species and, at the same time, appeared to increase the presence of Firmicutes and Lactobacillaceae in the bowel [31][32][33]. In two recent studies, astaxanthin has been shown to provide important protection toward intestinal mucosa by decreasing oxidative stress, stimulating calyciform cells and increasing IgA secretion.…”
Section: Anti-inflammatory and Gastrointestinal Protective Actionmentioning
confidence: 89%
See 1 more Smart Citation
“…The treatment of human macrophages with krill oil-rich in PUFAs and astaxanthin-resulted in a reduction in LPS-induced IL-1β and TNF-α expression in vitro in a concentration-dependent manner. Astaxanthin also decreased the amount of Rickettsiales and several Lactobacillus species and, at the same time, appeared to increase the presence of Firmicutes and Lactobacillaceae in the bowel [31][32][33]. In two recent studies, astaxanthin has been shown to provide important protection toward intestinal mucosa by decreasing oxidative stress, stimulating calyciform cells and increasing IgA secretion.…”
Section: Anti-inflammatory and Gastrointestinal Protective Actionmentioning
confidence: 89%
“…In two recent studies, astaxanthin has been shown to provide important protection toward intestinal mucosa by decreasing oxidative stress, stimulating calyciform cells and increasing IgA secretion. In addition, it decreased the loss of beneficial bacteria such as Lactobacillus and Bifidobacteria and affected Clostridium coccoides and Enterobacteriaceae: as a result, key metabolites of the gut microbiota, including acetic acid, propionic acid, butyric acid and other short-chain fatty acids, were indirectly increased, thereby improving gut function and immunity [33,34]. Further studies confirm that astaxanthin positively modulates the composition of the gut microbiota by optimizing the ratio Bacteroides/Firmicutes while improving the abundance of Akkermansia and Verrucomicrobia species, which protect the gut from pathogens [35][36][37].…”
Section: Anti-inflammatory and Gastrointestinal Protective Actionmentioning
confidence: 99%
“…The histological scores of colons were in accordance with the method reported by Zhang et al, according to the severity of mucosal inflammation, the degree of crypt damage, and the degree of epithelial damage. 48 Immunostaining. Colon tissue sections with a thickness of 4 μm were used for immunofluorescent and immunohistochemical evaluation.…”
Section: ■ Materials and Methodsmentioning
confidence: 99%
“…It is noteworthy that AST-Alg displayed a better protective effect on the colitis treatment compared to an oil-in-water emulsion form of AST, suggesting that a tissue-targeted delivery system could augment the potency of AST. In another study conducted by Zhang et al, AST-loaded nanocarriers utilizing cauliflower-like carriers were prepared, and the particles were examined in in vitro and DSS-treated mice [ 146 ]. In vitro studies showed that AST-loaded nanocarriers more effectively targeted mitochondria than a free form of AST, which significantly improved the internalization of AST and reduced ROS production in the mitochondria.…”
Section: Ulcerative Colitismentioning
confidence: 99%
“…In vitro studies showed that AST-loaded nanocarriers more effectively targeted mitochondria than a free form of AST, which significantly improved the internalization of AST and reduced ROS production in the mitochondria. In vivo studies using DSS-treated BALB/c mice further showed that AST-loaded nanocarriers (250 mg/kg; 13 days) protected the colon tissue integrity by inhibiting expressions of IL-1β, IL-6, COX-2, MPO, and iNOS and by activating the expression of zonula occludens-1 (ZO-1), which is an intestinal tight junction protein [ 146 ].…”
Section: Ulcerative Colitismentioning
confidence: 99%